Cargando…
Danqi Pill Protects Against Heart Failure Post-Acute Myocardial Infarction via HIF-1α/PGC-1α Mediated Glucose Metabolism Pathway
AIM: Heart failure (HF) post-acute myocardial infarction (AMI) leads to a large number of hospitalizations and deaths worldwide. Danqi pill (DQP) is included in the 2015 national pharmacopoeia and widely applied in the treatment of HF in clinics in China. We examined whether DQP acted on glucose met...
Autores principales: | Zhang, Qian, Guo, Dongqing, Wang, Yuanyuan, Wang, Xiaoping, Wang, Qiyan, Wu, Yan, Li, Chun, Wang, Wei, Wang, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187888/ https://www.ncbi.nlm.nih.gov/pubmed/32372956 http://dx.doi.org/10.3389/fphar.2020.00458 |
Ejemplares similares
-
Pro-angiogenic Role of Danqi Pill Through Activating Fatty Acids Oxidation Pathway Against Coronary Artery Disease
por: Jiao, Shihong, et al.
Publicado: (2018) -
Multitarget Effects of Danqi Pill on Global Gene Expression Changes in Myocardial Ischemia
por: Wang, Qiyan, et al.
Publicado: (2018) -
Danqi Pill regulates lipid metabolism disorder induced by myocardial ischemia through FATP-CPTI pathway
por: Wang, Yong, et al.
Publicado: (2015) -
Effect of DanQi Pill on PPARα, lipid disorders and arachidonic acid pathway in rat model of coronary heart disease
por: Chang, Hong, et al.
Publicado: (2016) -
Huoxue Huatan Decoction Ameliorates Myocardial Ischemia/Reperfusion Injury in Hyperlipidemic Rats via PGC-1α–PPARα and PGC-1α–NRF1–mtTFA Pathways
por: Lin, Fei, et al.
Publicado: (2020)